Sanofi announces carve-out creating EUROAPI and spin-off of approximately 58% of shares to its shareholders
Client(s) Sanofi
Jones Day advised Sanofi in the carve out creating EUROAPI (a leading European company dedicated to the development, production and marketing of active pharmaceutical ingredients) and the listing of this entity on Euronext Paris and the placement of 12% to the French State (through French Tech Souveraineté) for a price of up to €150 million.